Cheng-Cheng Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cheng-Cheng Wang has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Tiantian Zhang
Ocean University of China
13 shared publications - Yuming Wang
Ocean Univ China, Coll Food Sci & Engn, SKL Marine Food Proc & Safety Control, 1299 Sansha Rd, Qingdao 266404, Peoples R China
12 shared publications Changhu Xue
College of Food Science and Engineering Ocean University of China No. 5 Yushan Road Qingdao Shandong Province 266003 P.R. China
7 shared publicationsTeruyoshi Yanagita
Laboratory for Marine Drugs and Bioproducts Pilot National Laboratory for Marine Science and Technology (Qingdao) Qingdao Shandong Province 266237 P. R. China
7 shared publicationsLin Ding
College of Food Science and Engineering Ocean University of China No. 5 Yushan Road Qingdao 266003 P. R. China
6 shared publicationsChang-Hu Xue
College of Food Science and Engineering, Ocean University of China, No. 5 Yushan Road, Qingdao 266003, Shandong Province, P. R. China
5 shared publications
Latest Publications
- 4 July 2021
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 65 (17) , 2100009
Dietary EPA‐Enriched Phospholipids Alleviate Chronic Stress and LPS‐Induced Depression‐ and Anxiety‐Like Behavior by Regulating Immunity and Neuroinflammation
Scope: A growing number of studies have reported the effects of eicosapentaenoic acid (EPA) and terrestrial phospholipids on ameliorating mood disorders. Marine‐derived EPA‐enriched phospholipids (EPA‐PL) exhibit the structural characteristics of EPA and phospholipids. However, the effect of dietary EPA‐PL, and the differences between amphiphilic EPA‐PL and lyophobic EPA on mood disorders had not been studied.Methods and Results: A comparative investigation to determine the effects of dietary EPA‐enriched ethyl ester (EPA‐EE) and EPA‐PL on improving depression‐ and anxiety‐like behavior in a mouse model is performed, induced by 4 week chronic unpredictable mild stress (CUMS) coupled with lipopolysaccharide (LPS) challenge. It is found that dietary 4 week 0.6% (w/w) EPA‐PL rescued depression‐ and anxiety‐like behavior to a greater extent than did EPA‐EE. Moreover, dietary EPA‐PL significantly reduced the immobility time by 56.6%, close to the normal level, in forced swimming test, which revealed a reversal of depression‐like behavior. Further studies revealed that dietary EPA‐PL regulated immunity, monoamine systems, and the hypothalamic–pituitary–adrenal (HPA) axis by multi‐target interactions, including inhibition of neuroinflammation and apoptosis.Conclusion: EPA‐PL exerted superior effects to EPA‐EE in alleviating depression‐ and anxiety‐like behavior. The data suggest potential novel candidate or targeted dietary patterns to prevent and treat mood disorder.
- 4 July 2021
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 65 (17) , 2100009
Dietary EPA‐Enriched Phospholipids Alleviate Chronic Stress and LPS‐Induced Depression‐ and Anxiety‐Like Behavior by Regulating Immunity and Neuroinflammation
Scope: A growing number of studies have reported the effects of eicosapentaenoic acid (EPA) and terrestrial phospholipids on ameliorating mood disorders. Marine‐derived EPA‐enriched phospholipids (EPA‐PL) exhibit the structural characteristics of EPA and phospholipids. However, the effect of dietary EPA‐PL, and the differences between amphiphilic EPA‐PL and lyophobic EPA on mood disorders had not been studied.Methods and Results: A comparative investigation to determine the effects of dietary EPA‐enriched ethyl ester (EPA‐EE) and EPA‐PL on improving depression‐ and anxiety‐like behavior in a mouse model is performed, induced by 4 week chronic unpredictable mild stress (CUMS) coupled with lipopolysaccharide (LPS) challenge. It is found that dietary 4 week 0.6% (w/w) EPA‐PL rescued depression‐ and anxiety‐like behavior to a greater extent than did EPA‐EE. Moreover, dietary EPA‐PL significantly reduced the immobility time by 56.6%, close to the normal level, in forced swimming test, which revealed a reversal of depression‐like behavior. Further studies revealed that dietary EPA‐PL regulated immunity, monoamine systems, and the hypothalamic–pituitary–adrenal (HPA) axis by multi‐target interactions, including inhibition of neuroinflammation and apoptosis.Conclusion: EPA‐PL exerted superior effects to EPA‐EE in alleviating depression‐ and anxiety‐like behavior. The data suggest potential novel candidate or targeted dietary patterns to prevent and treat mood disorder.
- 2 July 2020
- Published by Wiley in Journal of Food Science
- Vol. 85 (7) , 2198-2206
Relationship between structure and efficacy of sea cucumber saponins echinoside A and its derivatives on hemolytic activity and prevention of nonalcoholic fatty liver disease
The hemolytic property discourages the development of sea cucumber saponins on alleviating lipids metabolism disturbance. The hemolytic activity of saponins has been reported to be highly correlative to their chemical structures. The aim of this study was to reduce the hemolytic activity of sea cucumber‐derived saponins echinoside A (EA) and simultaneously remain its effect on alleviating non‐alcoholic fatty liver disease (NAFLD) by structural modifications. Administration with EA and its derivatives for 8 weeks remarkably mitigated orotic acid‐induced NAFLD via inhibiting the activities and mRNA expressions of enzymes involved in lipogenesis, enhancing the activities and expressions of enzymes related to hepatic lipolysis in a rat model. Importantly, aglycone exhibited a distinct advantage in stimulating hepatic lipolysis compared with EA and dsEA, meanwhile possessed lowest hemolytic activity. This study may provide the theoretical basis to strengthen the application of sea cucumber saponins as food supplements and/or functional ingredients.
- 2 July 2020
- Published by Wiley in Journal of Food Science
- Vol. 85 (7) , 2198-2206
Relationship between structure and efficacy of sea cucumber saponins echinoside A and its derivatives on hemolytic activity and prevention of nonalcoholic fatty liver disease
The hemolytic property discourages the development of sea cucumber saponins on alleviating lipids metabolism disturbance. The hemolytic activity of saponins has been reported to be highly correlative to their chemical structures. The aim of this study was to reduce the hemolytic activity of sea cucumber‐derived saponins echinoside A (EA) and simultaneously remain its effect on alleviating non‐alcoholic fatty liver disease (NAFLD) by structural modifications. Administration with EA and its derivatives for 8 weeks remarkably mitigated orotic acid‐induced NAFLD via inhibiting the activities and mRNA expressions of enzymes involved in lipogenesis, enhancing the activities and expressions of enzymes related to hepatic lipolysis in a rat model. Importantly, aglycone exhibited a distinct advantage in stimulating hepatic lipolysis compared with EA and dsEA, meanwhile possessed lowest hemolytic activity. This study may provide the theoretical basis to strengthen the application of sea cucumber saponins as food supplements and/or functional ingredients.
- 19 April 2020
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 68 (19) , 5339-5348
Eicosapentaenoic Acid-Enriched Phosphoethanolamine Plasmalogens Alleviated Atherosclerosis by Remodeling Gut Microbiota to Regulate Bile Acid Metabolism in LDLR–/– Mice
EPA-enriched phosphoethanolamine plasmalogens (EPA-PlsEtns) might be retained in intestine rich in gut microbiota for a long time after treatment. It reminded us that EPA-PlsEtns might affect intestinal microbiota composition and its metabolites, which have been identified as a contributing factor in the development of cardiovascular. In the present study, EPA-PlsEtns administration for 8 weeks significantly reduced the atherosclerotic lesion area in LDLR-/- mice. Notably, the serum TC and LDL-c levels were significantly reduced by 33.6% and 38.2%, respectively, by EPA-PlsEtns instead of EPA in form of ethyl ester (EPA-EE) treatment compared with model group. EPA-PlsEtns administration also increased total neutral sterol and bile acids in feces by 92% and 39%, respectively, rather than EPA-EE. Mechanistically, EPA-PlsEtns might affect the abundance of gut microbiota contributing to the alteration of bile acid profiles, which might further accelerate bile acid synthesis via increasing CYP7A1 expression induced by the inhibition of FXR activation.
- 19 April 2020
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 68 (19) , 5339-5348
Eicosapentaenoic Acid-Enriched Phosphoethanolamine Plasmalogens Alleviated Atherosclerosis by Remodeling Gut Microbiota to Regulate Bile Acid Metabolism in LDLR–/– Mice
EPA-enriched phosphoethanolamine plasmalogens (EPA-PlsEtns) might be retained in intestine rich in gut microbiota for a long time after treatment. It reminded us that EPA-PlsEtns might affect intestinal microbiota composition and its metabolites, which have been identified as a contributing factor in the development of cardiovascular. In the present study, EPA-PlsEtns administration for 8 weeks significantly reduced the atherosclerotic lesion area in LDLR-/- mice. Notably, the serum TC and LDL-c levels were significantly reduced by 33.6% and 38.2%, respectively, by EPA-PlsEtns instead of EPA in form of ethyl ester (EPA-EE) treatment compared with model group. EPA-PlsEtns administration also increased total neutral sterol and bile acids in feces by 92% and 39%, respectively, rather than EPA-EE. Mechanistically, EPA-PlsEtns might affect the abundance of gut microbiota contributing to the alteration of bile acid profiles, which might further accelerate bile acid synthesis via increasing CYP7A1 expression induced by the inhibition of FXR activation.
- Open Access
- 1 March 2020
- Published by Tsinghua University Press in Food Science and Human Wellness
- Vol. 9 (1) , 88-94
The absorption kinetics of Antarctic krill oil phospholipid liposome in blood and the digestive tract of healthy mice by single gavage
- 1 March 2020
- Published by Tsinghua University Press in Food Science and Human Wellness
- Vol. 9 (1) , 88-94
Open AccessThe absorption kinetics of Antarctic krill oil phospholipid liposome in blood and the digestive tract of healthy mice by single gavage
- 9 January 2020
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 100 (5) , 2244-2251
Eicosapentaenoic acid‐enriched phospholipids suppressed lipid accumulation by specific inhibition of lipid droplet‐associated protein FSP27 in mice
BACKGROUND: Sea cucumber is a rich source of eicosapentaenoic acid in the form of eicosapentaenoic acid‐enriched phospholipids (EPA‐PL). It is known to be efficacious in preventing obesity. However, few studies have focused on the role of EPA‐PL in inhibiting lipid accumulation by lipid droplets (LDs). This study first investigated the effect of EPA‐PL from sea cucumber on the formation of LDs and the underlying mechanism in C57BL/6J mice. The mice were randomly divided into two groups and treated for 8 weeks or 3, 7, and 14 days with either (i) a high‐sucrose diet (model group), (ii) a high‐sucrose diet plus 2% EPA‐PL (EPA‐PL group).RESULTS: Eight‐week EPA‐PL supplementation significantly reduced lipid accumulation and LD size in liver and white adipose tissue (WAT), which was accompanied by the decreased expression of LDs‐associated protein FSP27. A 3‐day EPA‐PL treatment suppressed the mRNA expression of Fsp27. The mRNA level of Fsp27 reached its ‘normal level’ after withdrawing EPA‐PL for 7 days, suggesting that EPA‐PL might serve as a rapid regulator of FSP27. Furthermore, EPA‐PL increased the expression of lipolysis genes Hsl and Atgl accompanied by the regulation of Pparγ in WAT.CONCLUSIONS: Dietary EPA‐PL from sea cucumber (Cucumaria frondosa) protected against lipid accumulation by regulating LDs‐associated protein FSP27, which might provide novel evidence for the anti‐obesity action of EPA‐PL. © 2020 Society of Chemical Industry
- 9 January 2020
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 100 (5) , 2244-2251
Eicosapentaenoic acid‐enriched phospholipids suppressed lipid accumulation by specific inhibition of lipid droplet‐associated protein FSP27 in mice
BACKGROUND: Sea cucumber is a rich source of eicosapentaenoic acid in the form of eicosapentaenoic acid‐enriched phospholipids (EPA‐PL). It is known to be efficacious in preventing obesity. However, few studies have focused on the role of EPA‐PL in inhibiting lipid accumulation by lipid droplets (LDs). This study first investigated the effect of EPA‐PL from sea cucumber on the formation of LDs and the underlying mechanism in C57BL/6J mice. The mice were randomly divided into two groups and treated for 8 weeks or 3, 7, and 14 days with either (i) a high‐sucrose diet (model group), (ii) a high‐sucrose diet plus 2% EPA‐PL (EPA‐PL group).RESULTS: Eight‐week EPA‐PL supplementation significantly reduced lipid accumulation and LD size in liver and white adipose tissue (WAT), which was accompanied by the decreased expression of LDs‐associated protein FSP27. A 3‐day EPA‐PL treatment suppressed the mRNA expression of Fsp27. The mRNA level of Fsp27 reached its ‘normal level’ after withdrawing EPA‐PL for 7 days, suggesting that EPA‐PL might serve as a rapid regulator of FSP27. Furthermore, EPA‐PL increased the expression of lipolysis genes Hsl and Atgl accompanied by the regulation of Pparγ in WAT.CONCLUSIONS: Dietary EPA‐PL from sea cucumber (Cucumaria frondosa) protected against lipid accumulation by regulating LDs‐associated protein FSP27, which might provide novel evidence for the anti‐obesity action of EPA‐PL. © 2020 Society of Chemical Industry
- 2 January 2020
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 11 (2) , 1441-1454
A pilot study on the effects of DHA/EPA-enriched phospholipids on aerobic and anaerobic exercises in mice
DHA/EPA-PL andl-carnitine had significant effects on aerobic exercise, while astaxanthin improved anaerobic exercise. The possible mechanism involved carbohydrate and lipid metabolism, mitochondrial respiratory chain and tricarboxylic acid cycle.
- 2 January 2020
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 11 (2) , 1441-1454
A pilot study on the effects of DHA/EPA-enriched phospholipids on aerobic and anaerobic exercises in mice
DHA/EPA-PL andl-carnitine had significant effects on aerobic exercise, while astaxanthin improved anaerobic exercise. The possible mechanism involved carbohydrate and lipid metabolism, mitochondrial respiratory chain and tricarboxylic acid cycle.
- Open Access
- 22 October 2019
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 9 (58) , 33863-33871
The rapid effects of eicosapentaenoic acid (EPA) enriched phospholipids on alleviating exercise fatigue in mice
EPA-PL has rapid effects on alleviating exercise fatigue by inhibiting lactic acid accumulation, glycogen consumption and muscle injury.
- 22 October 2019
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 9 (58) , 33863-33871
Open AccessThe rapid effects of eicosapentaenoic acid (EPA) enriched phospholipids on alleviating exercise fatigue in mice
EPA-PL has rapid effects on alleviating exercise fatigue by inhibiting lactic acid accumulation, glycogen consumption and muscle injury.
- 18 February 2019
- Published by Wiley in European Journal of Lipid Science and Technology
- Vol. 121 (5)
Comparative Analyses of DHA‐Phosphatidylcholine Forage and Liposomes on Alzheimer's Disease in SAMP8 Mice
The present work comparatively evaluates the efficacy of docosahexaenoic acid – phosphatidylcholine (DHA‐PC) forage and liposome on Alzheimer's disease (AD) in the senescence‐accelerated prone 8 (SAMP8) mice and illustrates the potential mechanism. The dose of DHA‐PC in forage group (1% of total diets) is equal to that of liposome group. The results of Morris maze test show that both DHA‐PC forage and liposome obviously alleviated cognitive impairment (P < 0.05). Moreover, the administration of DHA‐PC liposome shows advantage than forage in reducing β‐amyloid (Aβ) accumulation (P < 0.05). Meanwhile, DHA‐PC forage exhibits excellent inhibition on the IL‐1β protein expression (P < 0.05) and improvement in the protein levels of SYN and BDNF (P < 0.05). These data are the first to perform comparative analysis of DHA‐PC forage and liposome on AD.Practical Applications: The outcomes in the present study might help to understand the bioactivities of DHA‐PC forage and liposomes, which might exert potential application value for dietary supplement with neuroprotective effects.Both docosahexaenoic acid – phosphatidylcholine (DHA‐PC) forage and liposome shows benefits in alleviating Alzheimer's disease development in senescence‐accelerated prone 8 mice by inhibiting β‐amyloid generation, oxidative stress, apoptosis, neural inflammation, and enhancing neurotrophins pathway in different degrees.
- 18 February 2019
- Published by Wiley in European Journal of Lipid Science and Technology
- Vol. 121 (5)
Comparative Analyses of DHA‐Phosphatidylcholine Forage and Liposomes on Alzheimer's Disease in SAMP8 Mice
The present work comparatively evaluates the efficacy of docosahexaenoic acid – phosphatidylcholine (DHA‐PC) forage and liposome on Alzheimer's disease (AD) in the senescence‐accelerated prone 8 (SAMP8) mice and illustrates the potential mechanism. The dose of DHA‐PC in forage group (1% of total diets) is equal to that of liposome group. The results of Morris maze test show that both DHA‐PC forage and liposome obviously alleviated cognitive impairment (P < 0.05). Moreover, the administration of DHA‐PC liposome shows advantage than forage in reducing β‐amyloid (Aβ) accumulation (P < 0.05). Meanwhile, DHA‐PC forage exhibits excellent inhibition on the IL‐1β protein expression (P < 0.05) and improvement in the protein levels of SYN and BDNF (P < 0.05). These data are the first to perform comparative analysis of DHA‐PC forage and liposome on AD.Practical Applications: The outcomes in the present study might help to understand the bioactivities of DHA‐PC forage and liposomes, which might exert potential application value for dietary supplement with neuroprotective effects.Both docosahexaenoic acid – phosphatidylcholine (DHA‐PC) forage and liposome shows benefits in alleviating Alzheimer's disease development in senescence‐accelerated prone 8 mice by inhibiting β‐amyloid generation, oxidative stress, apoptosis, neural inflammation, and enhancing neurotrophins pathway in different degrees.
- 8 February 2019
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 10 (3) , 1571-1581
DHA-PC protects kidneys against cisplatin-induced toxicity and its underlying mechanisms in mice
DHA-PC protected the kidney against cisplatin-induced toxicity through sirtuin 1 activation, the inhibition of oxidative stress and apoptosis.
- 8 February 2019
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 10 (3) , 1571-1581
DHA-PC protects kidneys against cisplatin-induced toxicity and its underlying mechanisms in mice
DHA-PC protected the kidney against cisplatin-induced toxicity through sirtuin 1 activation, the inhibition of oxidative stress and apoptosis.
- 15 January 2019
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 10 (2) , 938-950
Comparative studies of DHA-enriched phosphatidylcholine and recombination of DHA-ethyl ester with egg phosphatidylcholine on ameliorating memory and cognitive deficiency in SAMP8 mice
Docosahexaenoic acid-enriched phospholipids (DHA-PLs) are important bioactive components from marine foods, and are barely obtained by people living inland due to limited sources of commercial DHA-PLs compared to commercial DHA-TG and DHA-EE fish oil. Therefore, it is of significance to develop substitutions of DHA-PLs. In the present study, we comparatively investigated the effects of DHA-phosphatidylcholine (PC) and the recombination of DHA-ethyl ester (EE) with egg PC on improving the dysfunction of memory and cognition in senescence-accelerated prone 8 (SAMP8) mice and illustrated the possible underlying mechanisms. Results showed that DHA-PC exhibited stronger effects than the recombination of DHA-EE with egg PC on improving the dysfunction of memory and cognition via suppressing Aβ generation, neuro-inflammation and apoptosis, and improving neurotrophins. These findings suggested that DHA-PLs (DHA-PC) could not be substituted by the recombination of commercial fish oil with DHA-free PC in alleviating age-related memory loss and cognitive deficiency in SAMP8 mice, which provided a reference for the prevention and treatment of neurodegenerative diseases.
- 15 January 2019
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 10 (2) , 938-950
Comparative studies of DHA-enriched phosphatidylcholine and recombination of DHA-ethyl ester with egg phosphatidylcholine on ameliorating memory and cognitive deficiency in SAMP8 mice
Docosahexaenoic acid-enriched phospholipids (DHA-PLs) are important bioactive components from marine foods, and are barely obtained by people living inland due to limited sources of commercial DHA-PLs compared to commercial DHA-TG and DHA-EE fish oil. Therefore, it is of significance to develop substitutions of DHA-PLs. In the present study, we comparatively investigated the effects of DHA-phosphatidylcholine (PC) and the recombination of DHA-ethyl ester (EE) with egg PC on improving the dysfunction of memory and cognition in senescence-accelerated prone 8 (SAMP8) mice and illustrated the possible underlying mechanisms. Results showed that DHA-PC exhibited stronger effects than the recombination of DHA-EE with egg PC on improving the dysfunction of memory and cognition via suppressing Aβ generation, neuro-inflammation and apoptosis, and improving neurotrophins. These findings suggested that DHA-PLs (DHA-PC) could not be substituted by the recombination of commercial fish oil with DHA-free PC in alleviating age-related memory loss and cognitive deficiency in SAMP8 mice, which provided a reference for the prevention and treatment of neurodegenerative diseases.